Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review).

Saved in:
Bibliographic Details
Title: Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review).
Authors: Poojary R; Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77807-3260, USA., Song AF; Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77807-3260, USA., Song BS; Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77807-3260, USA., Song CS; Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77807-3260, USA., Wang L; Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77807-3260, USA., Song J; Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77807-3260, USA.
Source: Molecular and clinical oncology [Mol Clin Oncol] 2023 Oct 12; Vol. 19 (6), pp. 95. Date of Electronic Publication: 2023 Oct 12 (Print Publication: 2023).
Publication Type: Journal Article; Review
Journal Info: Publisher: Spandidos Publications UK Ltd Country of Publication: England NLM ID: 101613422 Publication Model: eCollection Cited Medium: Internet ISSN: 2049-9469 (Electronic) Linking ISSN: 20499450 NLM ISO Abbreviation: Mol Clin Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2049-9469
DOI:10.3892/mco.2023.2691